RadTag® blood irradiation indicators are used by hospitals and blood banks who irradiate blood to prevent transfusion-associated Graft vs. Host Disease (TAGVHD). For optimal patient safety, it is necessary to confirm that blood products have been irradiated according to standard guidelines. Failure to verify compliance with these guidelines can pose a risk to patients.
RadTag irradiation indicators were developed to meet these guideline requirements and are specially calibrated to verify that the dose of irradiation delivered falls within recommended ranges. RadTag indicators offer the best final validation that irradiated blood is safe to transfuse.
The RadTag RTG15 (Gamma) and RadTag RTX15 (X-ray) Min/Max indicators are designed for 25 Gy central dose delivery. In addition to confirming the central dose, these indicators also verify that the dose is over 15 Gy, but less than 50 Gy, in accordance with regulatory agency safety guidelines.
Intraventricular hemorrhage (IVH) and periventricular leukomalacia (PVL) are serious, potentially life-threatening conditions — here’s what NICU staff need to know.
Periventricular leukomalacia (PVL) is known to be a causing factor in the development of cerebral palsy and other neurological conditions. Here’s what you need to know.
Current peripheral arterial blood draw methods can lead to serious complications. Learn more about a new method that’s both safer and more efficient.